Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018))

Alice Baggi; Pietro Quaglino; Marco Rubatto; Roberta Depenni; Michele Guida; Paolo Antonio Ascierto; Claudia Trojaniello; Paola Queirolo; Maristella Saponara; Ketty Peris; Francesco Spagnolo; Luca Bianchi; Federica De Galitiis; Maria Concetta Potenza; Ilaria Proietti; Riccardo Marconcini; Andrea Botticelli; Vito Barbieri; Pietro Vittorio Barbieri; Lisa Licitra; Salvatore Alfieri; Sergio Alfieri; Corrado Ficorella; Alessio Cortellini; Maria Concetta Fargnoli; Teresa Troiani; Luca Tondulli; Manuel Zamparini; Paolo Bossi

doi:10.1016/j.ejca.2022.02.027

Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018))

Alice Baggi
, Pietro Quaglino
, Marco Rubatto
, Roberta Depenni
, Michele Guida
, Paolo Antonio Ascierto
, Claudia Trojaniello
, Paola Queirolo
, Maristella Saponara
, Ketty Peris
, Francesco Spagnolo
, Luca Bianchi
, Federica De Galitiis
, Maria Concetta Potenza
, Ilaria Proietti
, Riccardo Marconcini
, Andrea Botticelli
, Vito Barbieri
, Pietro Vittorio Barbieri
, Lisa Licitra

Salvatore Alfieri, Sergio Alfieri, Corrado Ficorella, Alessio Cortellini, Maria Concetta Fargnoli, Teresa Troiani, Luca Tondulli, Manuel Zamparini, Paolo Bossi

University of Brescia
University of Turin
University of Modena and Reggio Emilia
IRCCS Istituto tumori Giovanni Paolo II - Bari
IRCCS Istituto nazionale tumori Fondazione Giovanni Pascale - Napoli
IRCCS Istituto Europeo di Oncologia - Milano
San Martino Hospital Genoa
University of Rome Tor Vergata
IRCCS Istituto Dermopatico dell'Immacolata - Roma
University of Rome La Sapienza
University of Pisa
Azienda Ospedaliera Pugliese-Ciaccio
University of Milan
IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
University of L'Aquila
University of Campania Luigi Vanvitelli
Ospedale Policlinico

Research output: Contribution to journal › Article

Abstract

The authors regret that some Author information was incorrectly given in the published article. Author Manuel Zamparini was missed in the Author list, and the listed affiliation for Paola Queirolo was incorrect. The full and correct details for the Authors are: Paola Queirolo Division of Melanoma, Sarcomas and Rare Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy Manuel Zamparini University of Brescia, Department of Medical-Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, ASST-Spedali Civili, Brescia, Lombardia, ItalyThe Authors also note that values in the first column of Table 4 were mistakenly reversed for ‘Antibiotic intake (within 1 month before therapy)’ and ‘Haemoglobin’. The correct table in full is given here.

Original language	English
Pages (from-to)	309-310
Number of pages	2
Journal	European Journal of Cancer
Volume	166
DOIs	https://doi.org/10.1016/j.ejca.2022.02.027
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

cemiplimab

Access to Document

10.1016/j.ejca.2022.02.027

Fingerprint

Dive into the research topics of 'Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018))'. Together they form a unique fingerprint.

Cite this

Baggi, A., Quaglino, P., Rubatto, M., Depenni, R., Guida, M., Ascierto, P. A., Trojaniello, C., Queirolo, P., Saponara, M., Peris, K., Spagnolo, F., Bianchi, L., De Galitiis, F., Potenza, M. C., Proietti, I., Marconcini, R., Botticelli, A., Barbieri, V., Barbieri, P. V., ... Bossi, P. (2022). Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018)). European Journal of Cancer, 166, 309-310. https://doi.org/10.1016/j.ejca.2022.02.027

@article{7ce74db4b29847aea972326bfd095117,

title = "Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018))",

abstract = "The authors regret that some Author information was incorrectly given in the published article. Author Manuel Zamparini was missed in the Author list, and the listed affiliation for Paola Queirolo was incorrect. The full and correct details for the Authors are: Paola Queirolo Division of Melanoma, Sarcomas and Rare Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy Manuel Zamparini University of Brescia, Department of Medical-Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, ASST-Spedali Civili, Brescia, Lombardia, ItalyThe Authors also note that values in the first column of Table 4 were mistakenly reversed for {\textquoteleft}Antibiotic intake (within 1 month before therapy){\textquoteright} and {\textquoteleft}Haemoglobin{\textquoteright}. The correct table in full is given here.",

keywords = "cemiplimab, cemiplimab",

author = "Alice Baggi and Pietro Quaglino and Marco Rubatto and Roberta Depenni and Michele Guida and Ascierto, \{Paolo Antonio\} and Claudia Trojaniello and Paola Queirolo and Maristella Saponara and Ketty Peris and Francesco Spagnolo and Luca Bianchi and \{De Galitiis\}, Federica and Potenza, \{Maria Concetta\} and Ilaria Proietti and Riccardo Marconcini and Andrea Botticelli and Vito Barbieri and Barbieri, \{Pietro Vittorio\} and Lisa Licitra and Salvatore Alfieri and Sergio Alfieri and Corrado Ficorella and Alessio Cortellini and Fargnoli, \{Maria Concetta\} and Teresa Troiani and Luca Tondulli and Manuel Zamparini and Paolo Bossi",

year = "2022",

doi = "10.1016/j.ejca.2022.02.027",

language = "English",

volume = "166",

pages = "309--310",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

Baggi, A, Quaglino, P, Rubatto, M, Depenni, R, Guida, M, Ascierto, PA, Trojaniello, C, Queirolo, P, Saponara, M, Peris, K, Spagnolo, F, Bianchi, L, De Galitiis, F, Potenza, MC, Proietti, I, Marconcini, R, Botticelli, A, Barbieri, V, Barbieri, PV, Licitra, L, Alfieri, S, Alfieri, S, Ficorella, C, Cortellini, A, Fargnoli, MC, Troiani, T, Tondulli, L, Zamparini, M & Bossi, P 2022, 'Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018))', European Journal of Cancer, vol. 166, pp. 309-310. https://doi.org/10.1016/j.ejca.2022.02.027

Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018)). / Baggi, Alice; Quaglino, Pietro; Rubatto, Marco et al.
In: European Journal of Cancer, Vol. 166, 2022, p. 309-310.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018))

AU - Baggi, Alice

AU - Quaglino, Pietro

AU - Rubatto, Marco

AU - Depenni, Roberta

AU - Guida, Michele

AU - Ascierto, Paolo Antonio

AU - Trojaniello, Claudia

AU - Queirolo, Paola

AU - Saponara, Maristella

AU - Peris, Ketty

AU - Spagnolo, Francesco

AU - Bianchi, Luca

AU - De Galitiis, Federica

AU - Potenza, Maria Concetta

AU - Proietti, Ilaria

AU - Marconcini, Riccardo

AU - Botticelli, Andrea

AU - Barbieri, Vito

AU - Barbieri, Pietro Vittorio

AU - Licitra, Lisa

AU - Alfieri, Salvatore

AU - Alfieri, Sergio

AU - Ficorella, Corrado

AU - Cortellini, Alessio

AU - Fargnoli, Maria Concetta

AU - Troiani, Teresa

AU - Tondulli, Luca

AU - Zamparini, Manuel

AU - Bossi, Paolo

PY - 2022

Y1 - 2022

N2 - The authors regret that some Author information was incorrectly given in the published article. Author Manuel Zamparini was missed in the Author list, and the listed affiliation for Paola Queirolo was incorrect. The full and correct details for the Authors are: Paola Queirolo Division of Melanoma, Sarcomas and Rare Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy Manuel Zamparini University of Brescia, Department of Medical-Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, ASST-Spedali Civili, Brescia, Lombardia, ItalyThe Authors also note that values in the first column of Table 4 were mistakenly reversed for ‘Antibiotic intake (within 1 month before therapy)’ and ‘Haemoglobin’. The correct table in full is given here.

AB - The authors regret that some Author information was incorrectly given in the published article. Author Manuel Zamparini was missed in the Author list, and the listed affiliation for Paola Queirolo was incorrect. The full and correct details for the Authors are: Paola Queirolo Division of Melanoma, Sarcomas and Rare Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy Manuel Zamparini University of Brescia, Department of Medical-Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, ASST-Spedali Civili, Brescia, Lombardia, ItalyThe Authors also note that values in the first column of Table 4 were mistakenly reversed for ‘Antibiotic intake (within 1 month before therapy)’ and ‘Haemoglobin’. The correct table in full is given here.

KW - cemiplimab

UR - http://hdl.handle.net/10807/206063

U2 - 10.1016/j.ejca.2022.02.027

DO - 10.1016/j.ejca.2022.02.027

M3 - Article

SN - 0959-8049

VL - 166

SP - 309

EP - 310

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Baggi A, Quaglino P, Rubatto M, Depenni R, Guida M, Ascierto PA et al. Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018)). European Journal of Cancer. 2022;166:309-310. doi: 10.1016/j.ejca.2022.02.027

Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018))

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this